BIOMAT Database Logo BIOMAT Database Logo

Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. 1997

C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Clinique d'Oncologie et Radiothérapie, Hôpital Bretonneau, Tours, France.

OBJECTIVE To determine predictive factors and prognostic value of tumor downstaging and tumor sterilization after preoperative RT for rectal cancer. METHODS Between 1977 and 1994, 167 patients with a histologically proven adenocarcinoma (70 T2, 65 T3, 29 T4, and 3 local recurrences) underwent preoperative RT. Median dose was 44 Gy (5-73 Gy). Surgery was performed in a mean time of 5 weeks after RT. Pathologic specimens have been reviewed by the same pathologist in order to specify the modified Astler Coller classification (MAC), and to quantify the residual tumor cell density (RTCD). RESULTS According to the MAC, there was 9 stage 0 (5%), 10 stage A (6%), 103 stage B1-B3 (62%), and 45 stage C1-C3 (27%) tumors. Seventeen percent and 56% of the patients who received a dose > or = 44 Gy had respectively a 0-A and a B tumor, compared to 4 and 69% in those who received a dose < 44 Gy (p = 0.04). Tumor differentiation and a longer interval before surgery were significantly associated with a more frequent downstaging, and preoperative staging correlated well to the postoperative pathological findings. According to the RTCD, 62 tumors (37%) showed no or only rare foci of residual tumor cells (Group 1); 62 (37%) showed an intermediate RTCD (Group 2); and 43 (26%) a high RTCD (Group 3). No predictive factor of RTCD was statistically significant. In univariate analysis, postoperative staging was a significant prognostic factor, with corresponding 5-year overall survival rates in 0-A, B, and C stages of 92, 67, and 26% (p < 0.01). RTCD was not a prognostic factor. However, overall and disease-free survival rates for patients with complete pathologic response of 83% at 2 and 5 years suggested a better outcome in this subgroup of patients. CONCLUSIONS The favorable influence of higher doses of preoperative RT on pathologic stage has been observed. Tumor differentiation, preoperative classification and time before surgery were the other predictive factors of tumor downstaging. However, there was no predictive factor of complete pathologic response. Even after preoperative RT, postoperative staging remained a prognostic factor.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer.
January 2018, In vivo (Athens, Greece),
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer.
December 1998, International journal of radiation oncology, biology, physics,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
[Predictive factors of histologic effects in preoperative radiotherapy for rectal cancer].
September 2003, Nihon rinsho. Japanese journal of clinical medicine,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer.
December 2004, Japanese journal of clinical oncology,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome.
January 2006, Neoplasma,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
No downstaging after short-term preoperative radiotherapy in rectal cancer patients.
April 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
[Tumor downstaging through preoperative chemoradiotherapy in locally advanced rectal cancer].
January 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology],
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors.
January 2018, Journal of radiation oncology,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.
January 2008, British journal of cancer,
C Berger, and A de Muret, and P Garaud, and S Chapet, and P Bourlier, and A Reynaud-Bougnoux, and E Dorval, and L de Calan, and N Huten, and O le Folch, and G Calais
Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?
April 2005, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!